HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virus associated innate immunity in liver.

Abstract
Dendritic cells (DCs) sense virus via toll-like receptors (TLR) or retinoic acid inducible gene-I (RIG-I) and evoke a cascade of immune reactions. In myeloid DC (MDC) from hepatitis C virus (HCV)-infected patients, the levels of TLR/RIG-I-mediated IFN-beta or TNF-alfa induction are lower than those in uninfected donors, suggesting that their signal transduction in MDC is impaired. Dendritic cells in HCV infection are unresponsive to interferon (IFN)-alfa, thus failing to enhance MHC class-I related chain A/B and subsequent NK cell activation. Alternatively, NK cells from the patients down-regulate DC in the presence of HLA-E-expressing hepatocytes by secreting IL-10 and TGF-beta1. Such functional alteration of NK cells in HCV infection is ascribed to the enhanced expression of NKG2A/CD94. Activated NKT cells from the patients produce higher levels of IL-13 but comparable IFN-gamma with those from controls, showing their bias to Th2-type. In pegylated IFN-alfa/ribavirin therapy for chronic hepatitis C, improved DC function is related with successful HCV eradication. In conclusion, cross-talks among DCs and innate lymphocytes are critical in shaping immune response against HCV, either spontaneously or therapeutically.
AuthorsTatsuya Kanto
JournalFrontiers in bioscience : a journal and virtual library (Front Biosci) Vol. 13 Pg. 6183-92 (May 01 2008) ISSN: 1093-9946 [Print] United States
PMID18508652 (Publication Type: Journal Article, Review)
Chemical References
  • Toll-Like Receptors
Topics
  • Dendritic Cells (classification, immunology)
  • Hepatitis C (immunology)
  • Hepatitis, Viral, Human (immunology)
  • Humans
  • Immunity, Innate
  • Killer Cells, Natural (immunology)
  • Liver (immunology, virology)
  • Lymphocyte Subsets (immunology)
  • T-Lymphocytes (immunology)
  • Toll-Like Receptors (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: